Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
DetermaIO™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Oncocyte
Type:
Laboratory Developed Test
Related tests:
‹
DetermaCNI™
DetermaMx™
DetermaRx™
DetermaTx™
TNBCType-IM assay
TheraSure™-CNI MONITOR Assay
DetermaCNI™
DetermaMx™
DetermaRx™
DetermaTx™
TNBCType-IM assay
TheraSure™-CNI MONITOR Assay
›
Details
Evidence
News
Search handles
@BianchiniGP
@teamoncology
Search handles
@BianchiniGP
@teamoncology
Filter by
Latest
over1year
DetermaIO Assay Delineates Single-Agent Immunotherapy Benefit in NSCLC @BCCancer #lcsm #oncology https://t.co/kVXH6s7Syu ()
over 1 year ago
DetermaIO™
almost2years
Just published: Novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced NSCLC. Novel because it incorporates both "hot" and multiple mechanisms of "cold"-related genes. Ranganath et al. BMC Cancer. https://t.co/cUrRatotWg ()
almost 2 years ago
Checkpoint inhibition • Clinical
|
DetermaIO™
2years
I’d be interested to see if our DetermaIO biomarker test would be a good indicator for SCLC. ()
2 years ago
DetermaIO™
over2years
Our contribution to #PrecisionImmunology in TNBC at @SABCSSanAntonio GS1-00 Imaging mass cytometry PD10-06 Predictive value of DetermaIO PD10-09 Immune modulation by anthracyclines and taxanes P1-04-02 Biology of PD-L1 dynamic P2-07-12 IO score and TNBC dynamic #SABCS21 (@BianchiniGP)
over 2 years ago
PD-L1 (Programmed death ligand 1)
|
DetermaIO™
over2years
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer. Excited about this first to report this signature in TNBC https://t.co/u22F0vP5Ji #bcsm #OncoAlert via @Cancers_MDPI (@teamoncology)
over 2 years ago
Clinical
|
DetermaIO™
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login